https://scholars.lib.ntu.edu.tw/handle/123456789/582052
標題: | Control by Vaccination: Asian and Taiwan Experience | 作者: | JIA-HORNG KAO | 關鍵字: | Asia; HBV; HBV vaccine; HCC; Hepatitis B vaccination programme; Hepatitis B virus; Hepatocellular carcinoma; Taiwan | 公開日期: | 2011 | 出版社: | Wiley-Blackwell | 起(迄)頁: | 18-23 | 來源出版物: | Clinical Dilemmas in Primary Liver Cancer | 摘要: | Hepatocellular carcinoma (HCC) is one of the most common cancers and causes of cancer-related death worldwide. Most new cases of HCC occur in East or Southeast Asia. Overall, at least 75% of HCC are attributable to persistent viral infections with either hepatitis B virus (HBV) (50-55%) or hepatitis C virus (HCV) (25-30%). Strong geographic correlations have been found between the incidence of HCC and the prevalence of hepatitis B surface antigen or antibody to hepatitis C virus. In HBV endemic Asian countries, chronic HBV infection has the strongest association with the development of HCC. Safe and effective vaccines against HBV infection have been available for nearly three decades, and nationwide studies documented that the best and cheapest measure to prevent HBV-related HCC is the implementation of universal hepatitis B vaccination programme, by which the incidence rates of HCC in childhood and early adulthood are reduced in several Asian countries including Taiwan. ? 2012 by John Wiley & Sons, Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886350238&doi=10.1002%2f9781119962205.ch3&partnerID=40&md5=d2c55e2207fbfde72daf8b1166621fe7 https://scholars.lib.ntu.edu.tw/handle/123456789/582052 |
ISSN: | #VALUE! | DOI: | 10.1002/9781119962205.ch3 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。